Skip to main content

Dr. Mauricio Concha, MD

Neurology (Neurology Physician)

  • Medicare participating

At a glance

Years since graduation
40
In the NPI registry since
2006
Medicare patients seen, 2024
864

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Neurology Physician primary
    FL license ME69547

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Neurology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
864
Services billed
3,435
Patients’ average age
78
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes391291
Ultrasound of both sides of head and neck blood flow255253
Insertion of needle into vein for collection of blood sample130113
Established patient office or other outpatient visit, 40-54 minutes107104
New patient office or other outpatient visit, 60-74 minutes106106
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes104103
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes7660
Cyanocobalamin (vitamin b-12) level6462
Folic acid level, serum5655
Blood test, thyroid stimulating hormone (tsh)3434

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 17 companies reported 92 payments worth $48,068 in total to this clinician.

By type
Consulting Fee$22,513
Compensation for services other than consulting (speaking, faculty)$19,425
Travel and Lodging$3,895
Food and Beverage$2,236

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 31, 2025Lilly USA, LLC
Oct 31, 2025
Consulting Fee
KISUNLA · Neuroscience
$9,375
Nov 19, 2025Lilly USA, LLC
Nov 19, 2025
Consulting Fee
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$8,188
Sep 8, 2025Lilly USA, LLC
Sep 8, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$3,125
May 14, 2025Eli Lilly and Company
May 14, 2025
Consulting Fee$2,750
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Oct 31, 2025Lilly USA, LLC
Oct 31, 2025
Consulting Fee
KISUNLA · Neuroscience
$2,200
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,250
All 28 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Nov 26, 2025Lilly USA, LLC
Nov 26, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,250
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
$950
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
$950
Nov 25, 2025Lilly USA, LLC
Nov 25, 2025
Travel and Lodging
KISUNLA · Neuroscience · travel to OSPREY, FL
$17.50
Nov 19, 2025Lilly USA, LLC
Nov 19, 2025
Consulting Fee
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$8,188
Nov 14, 2025Lilly USA, LLC
Nov 14, 2025
Travel and Lodging
KISUNLA · Neuroscience · travel to BRADENTON, FL
$21.00
Nov 5, 2025Lilly USA, LLC
Nov 5, 2025
Travel and Lodging
travel to CANCÚN, Mexico · in-kind
$583
Nov 5, 2025Lilly USA, LLC
Nov 5, 2025
Travel and Lodging
travel to CANCÚN, Mexico · in-kind
$479
Nov 5, 2025Lilly USA, LLC
Nov 5, 2025
Travel and Lodging
travel to CANCÚN, Mexico · in-kind
$380
Nov 5, 2025Lilly USA, LLC
Nov 5, 2025
Travel and Lodging
travel to CANCÚN, Mexico · in-kind
$252
Oct 31, 2025Lilly USA, LLC
Oct 31, 2025
Consulting Fee
KISUNLA · Neuroscience
$9,375
Oct 31, 2025Lilly USA, LLC
Oct 31, 2025
Consulting Fee
KISUNLA · Neuroscience
$2,200
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
$950
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Travel and Lodging
travel to N/A, NC · in-kind
$428
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Travel and Lodging
travel to N/A, GA · in-kind
$366
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Travel and Lodging
travel to N/A, FL · in-kind
$231
Oct 24, 2025Lilly USA, LLC
Oct 24, 2025
Travel and Lodging
travel to N/A, FL · in-kind
$157
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$2,500
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$1,250
Oct 14, 2025Lilly USA, LLC
Oct 14, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
$950
Sep 8, 2025Lilly USA, LLC
Sep 8, 2025
Compensation for services other than consulting (speaking, faculty)
KISUNLA · Neuroscience
Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT.
$3,125
Jul 25, 2025Amgen Inc.
Jul 25, 2025
Travel and Lodging
travel to Dallas, TX · in-kind
$36.80
Jul 23, 2025Amgen Inc.
Jul 23, 2025
Travel and Lodging
travel to Dallas, TX · in-kind
$567
Jul 23, 2025Amgen Inc.
Jul 23, 2025
Travel and Lodging
travel to Dallas, TX · in-kind
$375
May 14, 2025Eli Lilly and Company
May 14, 2025
Consulting Fee$2,750

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 11 industry-funded studies in 2025, from 6 companies. The companies reported $841,781 in research payments for these studies, mostly to the institutions running them.

  • Time to Reversal Agents in
    AstraZeneca Pharmaceuticals LP
  • A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
    Eli Lilly and Company · Completed · NCT06538116
  • A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (Targe…
    E.r. Squibb & Sons, L.l.c.
  • A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or O…
    Amgen Inc.
  • A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
    Eli Lilly and Company · Active, not recruiting · NCT04437511
  • Study name not reported
    Novo Nordisk As
  • ITI-1284-201
    Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.)
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild-to-Moderate Alzheimer…
    E.r. Squibb & Sons, L.l.c.
  • A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
    Amgen Inc.
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
    E.r. Squibb & Sons, L.l.c. · Active, not recruiting · NCT06025578

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Neurology clinicians in Sarasota

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 16, 2024), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1093787780. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.